Revenue Performance - Consolidated revenues increased by $3,316,000 (10%) to $35,880,000 for the six months ended March 31, 2025, compared to $32,564,000 in the prior year[80]. - Approximately 76% of the Company's revenues during the six months ended March 31, 2025, were derived from Journal Technologies, with $1,753,000 (5%) from foreign countries[81]. - Revenues increased by $2,844,000 (12%) to $27,409,000 from $24,565,000 in the prior fiscal year period[96]. - Consolidated revenues were $18,176,000 and $16,571,000 for the three months ended March 31, 2025 and 2024, respectively, an increase of $1,605,000 (10%)[102]. - Approximately 76% of the Company's revenues during the three months ended March 31, 2025 were derived from Journal Technologies[103]. - Journal Technologies' revenues increased by $1,337,000 (11%) to $13,796,000 from $12,459,000 in the prior fiscal year period[111]. Income and Expenses - Consolidated operating expenses rose by $2,867,000 (9%) to $34,175,000 from $31,308,000, primarily due to increased salaries and employee benefits[82]. - Consolidated operating expenses increased by $1,275,000 (8%) to $17,213,000 from $15,938,000[104]. - Non-operating income increased by $39,356,000 (112%) to $74,460,000, driven by net unrealized gains on marketable securities of $72,799,000[83]. - Non-operating income increased by $40,320,000 (202%) to $60,039,000 from $19,987,000, primarily due to net unrealized gains on marketable securities[105]. - The Company's consolidated pretax income was $76,165,000 for the six months ended March 31, 2025, compared to $36,360,000 in the prior year[84]. - Net income for the six months ended March 31, 2025, was $55,565,000 ($40.34 per share), up from $28,030,000 ($20.36 per share) in the prior year[84]. - Consolidated net income was $44,670,000 ($32.43 per share) for the three months ended March 31, 2025, compared to $15,415,000 ($11.19 per share) in the prior fiscal year period[106]. Marketable Securities - The aggregate fair market value of the Company's marketable securities was $431,490,000, with net unrealized gains of approximately $292,396,000[85]. - Cash and cash equivalents, restricted cash, and marketable security positions increased by $71,853,000 during the three months ended March 31, 2025[114]. Taxation - The effective tax rate for the six months ended March 31, 2025, was 27%, influenced by taxes on unrealized gains on marketable securities[86]. Accounting Policies and Risks - The Company prepares financial statements in accordance with U.S. generally accepted accounting principles, with critical accounting policies including revenue recognition and income taxes[119]. - The critical accounting policies are detailed in the Annual Report on Form 10-K for the year ended September 30, 2024[120]. - The Quarterly Report includes forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from expectations[121]. - Factors that could affect actual results include risks associated with software development, reliance on professional services engagements, and potential declines in subscriber revenues[121]. - The Company disclaims any intention to revise forward-looking statements based on new information or future developments[121]. - Important factors affecting forward-looking statements are discussed in the Form 10-Q and the Annual Report on Form 10-K[121]. - The Company faces risks from disruptive technologies like artificial intelligence and changes in the costs of postage and paper[121]. - Potential security breaches of the Company's software or websites could impact operations[121]. - Changes in accounting guidance and material weaknesses in internal control over financial reporting are also risks[121]. - General economic conditions, particularly in California, may influence the Company's performance[121].

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41048 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) (I.R.S. Employer Identification Number) 400 W. Morse Boulevard, Suite 220 Winter Park, FL 32789 (Address of Principal Executive ...

For the quarterly period ended March 31, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number 001-40903 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) | Delaware | 84-3559776 | | --- ...

Financing Activities - Hyperscale Data issued a convertible promissory note of $1.9 million on February 5, 2025, with a 15% annual interest rate, convertible at $4.00 per share [122]. - An amended and restated convertible promissory note of $3.5 million was issued on February 2025, accruing interest at 18% per annum, convertible at $2.00 per share [123]. - On March 14, 2025, a convertible promissory note of $4.2 million was issued, accruing interest at 15% per annum, with a conversion price based on the greater of $0.40 or 75% of the VWAP [124]. - The company entered into a securities purchase agreement on March 31, 2025, to sell up to 50,000 shares of Series B Convertible Preferred Stock for a total of $50.0 million [127]. - Each share of Series B Preferred Stock has a stated value of $1,000.00 and is convertible at a maximum price of $10.00 per share, with a cumulative cash dividend of 15% per annum [128]. - The company issued a total of 52,700 shares of Series D preferred stock for the settlement of equity line of credit advances totaling $0.6 million from April 1, 2025, through May 15, 2025 [172]. - A convertible promissory note with a principal face amount of $1.7 million was issued on April 1, 2025, accruing interest at 15% per annum, maturing on September 30, 2025 [173]. - The company entered into securities purchase agreements on April 15, 2025, issuing convertible promissory notes with an aggregate principal face amount of $5.0 million for gross consideration of $4.0 million [175]. - The Notes issued on April 15, 2025, have an original issue discount of 20%, or $1.0 million, and will mature on September 30, 2025 [176]. - The company made payments of $1.9 million in preferred dividends and $0.3 million on convertible notes payable [178]. Financial Performance - Total revenue for the three months ended March 31, 2025, was $25.02 million, a decrease of 35% from $38.37 million in the same period of 2024 [144]. - Revenue from crypto assets mining decreased by $6.25 million, or 55%, to $5.20 million due to a decline in mined crypto assets and increased mining difficulty [144][145]. - Crane operations revenue increased by $0.85 million, or 7%, to $13.77 million, driven by improved utilization of the crane fleet [146]. - Revenues from lending and trading activities dropped to approximately $0, a decrease of $9.13 million, primarily due to the transfer of shares affecting prior year revenue [147]. - Gross margins declined to 21% for the three months ended March 31, 2025, compared to 47% for the same period in 2024, largely due to poor performance in lending and trading activities [152]. - Selling and marketing expenses decreased by $1.7 million, or 42%, to $2.33 million, attributed to lower advertising and promotion costs [154]. - General and administrative expenses decreased by $1.2 million, or 11%, to $9.20 million, mainly due to lower professional fees and salaries [155]. - Other expense, net was $4.0 million for the three months ended March 31, 2025, down from $10.5 million in the same period of 2024 [156]. Cash Flow - As of March 31, 2025, cash and cash equivalents were $4.2 million, a slight decrease from $4.5 million as of December 31, 2024 [165]. - Net cash used in operating activities totaled $4.0 million for the three months ended March 31, 2025, compared to $10.2 million for the same period in 2024 [166]. - Net cash used in investing activities was $1.2 million for the three months ended March 31, 2025, a decrease from $1.7 million for the same period in 2024 [167]. - Net cash provided by financing activities was $4.7 million for the three months ended March 31, 2025, down from $13.0 million in the same period of 2024 [168]. Impairments and Gains - Hyperscale Data recognized a gain of $2.0 million from the deconsolidation of GIGA, which filed for Chapter 11 bankruptcy on August 14, 2024 [133]. - A gain of $10.0 million was recognized from the deconsolidation of AVLP, which filed for liquidation under Chapter 7 on March 28, 2025 [137]. - The company recorded an impairment loss of $8.0 million related to AGREE hotel properties during the year ended December 31, 2024 [136]. Strategic Initiatives - Hyperscale Data aims to maximize stockholder value through various initiatives, including public offerings and sales of subsidiaries [138]. - The company has provided capital and expertise to support growth in sectors such as AI software, social gaming, and hotel operations [140]. Accounting and Risk Disclosures - There have been no material changes to critical accounting estimates previously disclosed in the 2024 Annual Report [179]. - Market risk disclosures are not applicable for a smaller reporting company [180].

Financing Activities - The company issued a convertible promissory note of $1.9 million on February 5, 2025, with a conversion price of $4.00 per share and an interest rate of 15% per annum [122]. - An amended and restated convertible promissory note of $3.5 million was issued on February 2025, convertible at $2.00 per share, accruing interest at 18% per annum [123]. - On March 14, 2025, the company issued a convertible promissory note of $4.2 million, with a conversion price based on the greater of $0.40 or 75% of the VWAP [124]. - The company entered into a securities purchase agreement on March 31, 2025, to sell up to 50,000 shares of Series B Convertible Preferred Stock for a total of $50.0 million [127]. - Each share of Series B Preferred Stock has a stated value of $1,000.00 and is convertible at a maximum price of $10.00 per share, with a cumulative cash dividend of 15% per annum [128]. - The company issued a total of 52,700 shares of Series D preferred stock for the settlement of equity line of credit advances totaling $0.6 million from April 1, 2025, through May 15, 2025 [172]. - A convertible promissory note with a principal face amount of $1.7 million was issued on April 1, 2025, with an original issue discount of 10% and an interest rate of 15% per annum [173]. - The company entered into securities purchase agreements on April 15, 2025, issuing convertible promissory notes with an aggregate principal face amount of $5.0 million for gross consideration of $4.0 million [175]. - The Notes issued on April 15, 2025, have an original issue discount of 20%, amounting to $1.0 million, and will mature on September 30, 2025 [176]. - Payments of preferred dividends amounted to $1.9 million, with additional gross proceeds of $0.9 million from sales of Series G preferred stock [178]. Financial Performance - Total revenue for the three months ended March 31, 2025, was $25.02 million, a decrease of 35% from $38.37 million in the same period of 2024 [144]. - Revenue from crypto assets mining decreased by $6.25 million, or 55%, to $5.20 million due to a decline in mined crypto assets and increased mining difficulty [144][145]. - Crane operations revenue increased by $0.85 million, or 7%, to $13.77 million, driven by improved utilization of the crane fleet [146]. - Revenues from lending and trading activities dropped to approximately $0, a decrease of $9.13 million, or 100%, compared to $9.10 million in the prior year [147]. - Gross margins declined to 21% for the three months ended March 31, 2025, down from 47% in the same period of 2024 [152]. - Selling and marketing expenses decreased by $1.7 million, or 42%, to $2.33 million, primarily due to lower advertising costs [154]. - General and administrative expenses decreased by $1.2 million, or 11%, to $9.20 million, attributed to lower professional fees and salaries [155]. - Other expense, net was $4.0 million for the three months ended March 31, 2025, compared to $10.5 million in the same period of 2024 [156]. Cash Flow - Cash and cash equivalents as of March 31, 2025, were $4.2 million, a slight decrease from $4.5 million as of December 31, 2024 [165]. - Net cash used in operating activities totaled $4.0 million for the three months ended March 31, 2025, compared to $10.2 million in the same period of 2024 [166]. - Net cash used in investing activities was $1.2 million for the three months ended March 31, 2025, a decrease from $1.7 million for the same period in 2024 [167]. - Net cash provided by financing activities was $4.7 million for the three months ended March 31, 2025, down from $13.0 million in the same period of 2024 [168]. Gains and Losses - The company recognized a gain of $2.0 million from the deconsolidation of GIGA, which filed for Chapter 11 bankruptcy on August 14, 2024 [133]. - A gain of $10.0 million was recognized from the deconsolidation of AVLP, which filed for liquidation under Chapter 7 on March 28, 2025 [137]. - The company recorded an impairment loss of $8.0 million related to the real estate assets of AGREE during the year ended December 31, 2024 [136]. - The company recognized a loss of $1.0 million related to the Orchid convertible promissory note and a loss of $1.3 million related to the SJC convertible promissory note issued in March 2025 [168]. Strategic Initiatives - The company aims to maximize stockholder value through various initiatives, including public offerings and sales of subsidiaries [138]. - The company has provided capital to support growth in sectors such as AI software, social gaming, and hotel operations [140]. Accounting and Reporting - There have been no material changes to critical accounting estimates previously disclosed in the 2024 Annual Report [179]. - The company reported no applicable market risk disclosures as it qualifies as a smaller reporting company [180].

Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 001-39555 GREENWICH LIFESCIENCES, INC. Form 10-Q (Exact Name of registrant as specified in its charter) (Mark One) (Address of principal executive offices) (Zip Code) ( ...

Financial Performance - Evolv generated revenue of $32.0 million for the three months ended March 31, 2025, compared to $22.2 million for the same period in 2024, representing a year-over-year increase of 44%[158]. - The company reported a net loss of $1.7 million for the three months ended March 31, 2025, significantly improved from a net loss of $11.3 million in the same period of 2024[158]. - Total revenue for the three months ended March 31, 2025, was $32,007,000, representing a 44% increase from $22,181,000 in the same period of 2024[185]. - Subscription revenue increased by 35% to $19,237,000 in Q1 2025, up from $14,219,000 in Q1 2024[188]. - The net loss for the three months ended March 31, 2025, was $1,689,000, an 85% improvement from a net loss of $11,272,000 in the same period of 2024[185]. - Cash used in operating activities decreased from $16.2 million in Q1 2024 to $2.5 million in Q1 2025, indicating improved cash flow management[210]. - The company expects to continue generating losses for the foreseeable future, necessitating careful investment and potential additional capital[202]. Revenue Streams and Customer Growth - Evolv's solutions are primarily offered under a multi-year subscription model, which provides predictable revenue streams and is increasingly being adopted by customers[150]. - The company added 54 new customers during the three months ended March 31, 2025, contributing to revenue growth[186]. - License fee and other revenue surged by 205% to $3,718,000 in Q1 2025, compared to $1,219,000 in Q1 2024[190]. Cost Management and Expenses - Sales and marketing costs are anticipated to decrease for the year ending December 31, 2025, due to cost-cutting measures including a reduction in force implemented in January 2025[175]. - General and administrative expenses rose significantly due to legal and consulting fees, expected to continue through Q2 2025[176]. - Research and development expenses decreased by 24% to $4,862,000 in Q1 2025, down from $6,396,000 in Q1 2024[191]. - Sales and marketing expenses decreased by $4.8 million (30%) from $15.9 million in Q1 2024 to $11.0 million in Q1 2025, primarily due to reductions in personnel-related costs and advertising expenses[193]. - General and administrative expenses increased by $3.2 million (27%) from $11.8 million in Q1 2024 to $15.0 million in Q1 2025, driven by a significant rise in non-recurring professional fees[194]. - The company incurred restructuring costs of $2.7 million in Q1 2025, primarily related to a reduction in force[195]. Product and Technology - Evolv's flagship product, Evolv Express, utilizes AI-powered software to enhance security screening and improve visitor experience, distinguishing between threats and harmless items[148]. - Evolv's innovative technology aims to address the growing demand for safer environments in venues such as sports, education, and healthcare facilities[146]. Market Dynamics and Future Outlook - The company expects fluctuations in revenue and operating results due to factors such as inflation, supply chain issues, and shifts towards touchless security screening[153][154]. - The company is focused on expanding its market presence in various verticals, particularly in the United States, while adapting pricing strategies to regional dynamics[156]. - The company anticipates a decrease in general and administrative expenses in the second half of 2025 as ongoing investigations conclude[176]. Financial Position and Cash Flow - As of March 31, 2025, the company had $35.0 million in cash, cash equivalents, and marketable securities, down from a net income of $11.3 million in Q1 2024 to a net loss of $1.7 million in Q1 2025[200]. - Cash provided by financing activities was less than $0.1 million in Q1 2025, indicating limited financing activity compared to $0.3 million used in Q1 2024[216]. - Total future minimum lease payments under noncancelable operating leases amount to $19.1 million as of March 31, 2025[208]. Accounting and Reporting - No material changes to critical accounting estimates during the three months ended March 31, 2025[218]. - The company is classified as a smaller reporting company and is not required to provide certain market risk disclosures[219].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to Commission file number: 001-39417 ___________________________________ Evolv Technologies Holdings, Inc. (Exact Name of Reg ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report For the transition period from to Commission file number 1-15240 JAMES HARDIE INDUSTRIES plc ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHA ...

CureVac N.V. Unaudited Interim Condensed Consolidated Financial Statements As of March 31, 2025 and December 31, 2024 and for the three months ended March 31, 2025 and 2024 CureVac N.V. Unaudited Interim Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) | | | Three months ended March 31, | | | --- | --- | --- | --- | | (in thousands of EUR, except per share amounts) | Note | 2024 | 2025 | | Revenue | 3.1 | 12,373 | 893 | | Cost of sales | 3.2 | (41,690) | (875) | | Sellin ...